Fundz

Taiwan’s cancer focused Anbogen raises $12.5M in series A round

PRIVATEFeb 02, 2024

Amount Raised

$12.5 Million

Round Type

Series A

TaipeiBiotechnology

Description

Taipei-based precision oncology firm Anbogen Therapeutics Inc. drew $12.5 million in a series A funding round to propel two major clinical assets in its cancer pipeline.

Quick answer

Anbogen Therapeutics raised $12.5 Million in a Series A round, dated February 2, 2024. Anbogen Therapeutics is based in Taipei, Taipei City, Taiwan.

How much did Anbogen Therapeutics raise?
Anbogen Therapeutics raised $12.5 Million in a Series A round on February 2, 2024.
What does Anbogen Therapeutics do?
Anbogen Therapeutics is a clinical stage precision oncology company dedicated in developing first/best-in-class personalized therapeutics and making difference in patients' life.
Where is Anbogen Therapeutics based and how big is it?
Anbogen Therapeutics is based in Taipei, Taipei City, Taiwan.
Who are the decision-makers at Anbogen Therapeutics?
Fundz holds 1 contact at Anbogen Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Anbogen Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • UpHill Health raised $7M (Funding Round) on March 18, 2024.
  • BrickBio raised an undisclosed amount (Funding Round) on March 18, 2024.
  • Aprea Therapeutics raised $34M (Funding Round) on March 18, 2024.
  • CryoLogyx raised $637K (Seed) on March 18, 2024.
  • Spineart raised $21M (Convertible Note) on March 18, 2024.
  • ConKay Medical Systems raised $1.8M (Seed) on March 18, 2024.

Who to call at Anbogen Therapeutics, and when

A new round usually means Anbogen Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Anbogen Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Anbogen Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Anbogen Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Anbogen Therapeutics

Location

Taipei, Taipei City, Taiwan

About

Anbogen Therapeutics is a clinical stage precision oncology company dedicated in developing first/best-in-class personalized therapeutics and making difference in patients' life. We bridge the gap between discovery candidates and proof-of-concept indications to challenge the unmet needs. Headquartered in Taiwan, we are advancing a pipeline of precision medicines for the treatment of solid tumors. Currently with three assets including ABT-101 and ABT-301 under clinical development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Anbogen Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Anbogen Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Anbogen Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.